Michael L Eisenberg1, Katsuto Shinohara. 1. Department of Urology, University of California-San Francisco, San Francisco, California 94143-1695, USA. eisenbergm@urology.ucsf.edu
Abstract
OBJECTIVES: To determine the efficacy of partial cryoablation of the prostate in the salvage setting. METHODS: All patients who were treated between April 2004 and September 2007 for recurrent prostate adenocarcinoma after failure of primary radiotherapy by means of partial cryoablation were identified. RESULTS: Nineteen patients met inclusion criteria; 15 had >6 months' follow-up. Mean age was 71 years. Men received salvage therapy a mean of 6 years after primary radiotherapy. Median follow-up was 18 months (range, 6-33 months). The biochemical recurrence-free survival rate (according to the American Society for Therapeutic Radiology and Oncology definition) was 89%, 67%, and 50% at 1, 2, and 3 years, respectively. One of 10 patients harbored residual carcinoma on routine follow-up biopsy at 1 year, whereas 50% harbored residual benign prostate tissue. Complications included incontinence (1), urethral stricture (1), and urethral ulcer (1). CONCLUSIONS: In properly selected patients with a unilateral focus of disease recurrence after radiotherapy, acceptable oncologic results can be achieved with partial cryoablation of the prostate, with low morbidity.
OBJECTIVES: To determine the efficacy of partial cryoablation of the prostate in the salvage setting. METHODS: All patients who were treated between April 2004 and September 2007 for recurrent prostate adenocarcinoma after failure of primary radiotherapy by means of partial cryoablation were identified. RESULTS: Nineteen patients met inclusion criteria; 15 had >6 months' follow-up. Mean age was 71 years. Men received salvage therapy a mean of 6 years after primary radiotherapy. Median follow-up was 18 months (range, 6-33 months). The biochemical recurrence-free survival rate (according to the American Society for Therapeutic Radiology and Oncology definition) was 89%, 67%, and 50% at 1, 2, and 3 years, respectively. One of 10 patients harbored residual carcinoma on routine follow-up biopsy at 1 year, whereas 50% harbored residual benign prostate tissue. Complications included incontinence (1), urethral stricture (1), and urethral ulcer (1). CONCLUSIONS: In properly selected patients with a unilateral focus of disease recurrence after radiotherapy, acceptable oncologic results can be achieved with partial cryoablation of the prostate, with low morbidity.
Authors: Carlo Magno; Giuseppe Mucciardi; Alessandro Galì; Rosa Pappalardo; Francesco Lembo; Giuseppina Anastasi; Salvatore Butticè; Giorgio Ascenti; Franco Lugnani Journal: Ther Adv Urol Date: 2015-10
Authors: Kristin A Kinsman; Mariah L White; Lance A Mynderse; Akira Kawashima; Karen Rampton; Krzysztof R Gorny; Thomas D Atwell; Joel P Felmlee; Matthew R Callstrom; David A Woodrum Journal: Cardiovasc Intervent Radiol Date: 2017-10-17 Impact factor: 2.740
Authors: Wei Phin Tan; Ahmed ElShafei; Alireza Aminsharifi; Ahmad O Khalifa; Thomas J Polascik Journal: Clin Genitourin Cancer Date: 2019-12-05 Impact factor: 2.872
Authors: A Kanthabalan; M Arya; S Punwani; A Freeman; A Haroon; J Bomanji; M Emberton; H U Ahmed Journal: World J Urol Date: 2013-12 Impact factor: 4.226
Authors: Massimo Valerio; Hashim U Ahmed; Mark Emberton; Nathan Lawrentschuk; Massimo Lazzeri; Rodolfo Montironi; Paul L Nguyen; John Trachtenberg; Thomas J Polascik Journal: Eur Urol Date: 2013-06-06 Impact factor: 20.096